3.00
Relay Therapeutics Inc (RLAY) 最新ニュース
Relay Therapeutics, Inc. (RLAY): A Bull Case Theory - MSN
Relay Therapeutics to Participate in Two Upcoming Investor Conferences - The Manila Times
Guggenheim Lowers Price Target for Relay Therapeutics (RLAY) to $10.00 | RLAY Stock News - GuruFocus
Relay Therapeutics (RLAY) Stock Target Reduced Amid Strategic Changes and Progress | RLAY Stock News - GuruFocus
Relay Therapeutics Inc (RLAY) Q1 2025 Earnings: EPS Loss of $0.4 - GuruFocus
Relay Therapeutics (RLAY) Reports Decline in Q1 Revenue | RLAY S - GuruFocus
Relay Therapeutics Extends Cash Runway and Advances Clinical Trials - TipRanks
Relay Therapeutics Reports First Quarter 2025 Financial Results and Corporate Updates | RLAY Stock News - GuruFocus
Relay Therapeutics Inc reports results for the quarter ended March 31Earnings Summary - TradingView
Relay Therapeutics, Inc. SEC 10-Q Report - TradingView
Relay Therapeutics Reports First Quarter 2025 Financial Results and Corporate Updates - The Manila Times
Relay Therapeutics Extends Cash Runway into 2029 Amid Clinical Trial Advancements - Nasdaq
Layoff Tracker: Pliant Cuts 45% of Staff To Extend Cash Runway - BioSpace
Barclays PLC Has $1.29 Million Stake in Relay Therapeutics, Inc. (NASDAQ:RLAY) - Defense World
Invesco Ltd. Acquires 5,261 Shares of Relay Therapeutics, Inc. (NASDAQ:RLAY) - Defense World
There Is A Lot Of Upside Potential For Relay Therapeutics Inc(NASDAQ: RLAY) - Stocksregister
why Relay Therapeutics Inc [RLAY] is a Good Choice for Investors After New Price Target of $17.40 - dbtnews.com
Relay Therapeutics executive sells $36,540 in stock By Investing.com - Investing.com Nigeria
Relay Therapeutics executive sells $36,540 in stock - Investing.com Australia
LPL Financial LLC Sells 6,564 Shares of Relay Therapeutics, Inc. (NASDAQ:RLAY) - Defense World
Relay Therapeutics president sells $95,381 in stock By Investing.com - Investing.com South Africa
Relay Therapeutics chief legal officer sells $44,040 in stock By Investing.com - Investing.com South Africa
Relay Therapeutics CFO sells shares worth $44,246 By Investing.com - Investing.com South Africa
Relay Therapeutics Inc Stock: Executives Sell Shares Amid Mixed Signals - sharewise
Relay Therapeutics president sells $95,381 in stock - Investing.com Australia
Relay Therapeutics CFO sells shares worth $44,246 - Investing.com Australia
Relay Therapeutics chief legal officer sells $44,040 in stock - Investing.com
Relay Therapeutics Executives Sell Shares to Cover Tax Obligations and Under Trading Plan - TradingView
Healthy Upside Potential: Relay Therapeutics Inc (RLAY) - Sete News
Trading Day Review: Relay Therapeutics Inc (RLAY) Loses Momentum, Closing at 3.10 - DWinneX
Relay Therapeutics Inc: Weathering Stock Market Storms with 528.51M Market Cap - investchronicle.com
Relay Therapeutics, Inc. (NASDAQ:RLAY) Shares Sold by Legal & General Group Plc - Defense World
RLAY (Relay Therapeutics Inc) may reap gains as insiders became active recently - knoxdaily.com
Relay Therapeutics Inc (RLAY) shows promising results - uspostnews.com
Relay Therapeutics to Announce First Quarter 2025 Financial Resu - GuruFocus
Relay Therapeutics to Announce First Quarter 2025 Financial Results and Corporate Highlights on May 5, 2025 - The Manila Times
Relay Therapeutics Q1 2025 Earnings: Precision Medicine Pioneer Reports Financial Results May 5 - Stock Titan
Russell Investments Group Ltd. Has $329,000 Stock Holdings in Relay Therapeutics, Inc. (NASDAQ:RLAY) - Defense World
Relay Therapeutics (RLAY) Expected to Announce Quarterly Earnings on Thursday - Defense World
Ready to Jump After Recent Trade: Relay Therapeutics Inc (RLAY) - Sete News
Keeping an Eye on Relay Therapeutics Inc (RLAY) After Insider Trading Activity - knoxdaily.com
Upward Trajectory: Relay Therapeutics Inc (RLAY) Posts a Gaine, Closing at 2.93 - DWinneX
Relay Therapeutics Inc (RLAY)’s highs and lows: A closer look at its stock price fluctuations - uspostnews.com
Small Cap Stock Relay Therapeutics Inc (RLAY) Is A Buy – Analysts - Marketing Sentinel
Relay Therapeutics, Inc. (NASDAQ:RLAY) Stock Position Lifted by Geode Capital Management LLC - Defense World
Relay Therapeutics Reports Third Quarter 2024 Financial Results and Corporate Highlights - ADVFN
Relay Therapeutics, Inc. (NASDAQ:RLAY) Receives Average Recommendation of “Moderate Buy” from Brokerages - Defense World
大文字化:
|
ボリューム (24 時間):